Vice President, Strategy and Portfolio Planning

Vir Biotechnology•San Francisco, CA

2h•Hybrid

About The Position

Vir Biotechnology is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. The company is committed to creating a supportive environment for its colleagues. The Vice President, Strategy & Portfolio Planning, reporting to the Chief Business Officer, will be responsible for guiding the company's strategy and optimizing its portfolio of programs, products, and partnerships. This visible leadership position works across all business units. You will serve as a thoughtful strategic partner to the CBO and executive leadership team, driving corporate strategy and portfolio prioritization. You will optimize Vir Bio's business, translate enterprise-level strategies into actions, and align the organization to the strategy. Working closely with competitive intelligence, business development, and alliance management CBO sub-teams, you will develop Vir Bio's long-term strategic plan and lead integrated asset-level strategies across clinical and preclinical-stage programs. An enterprise leader, you will apply analytical rigor, translate complex clinical, scientific, and financial data into clear recommendations, articulate strategy, and work collaboratively across the company. You’ll thrive in this role if you love shaping big-picture strategy in fast-moving biotech environments, get energized by steering clinical-stage portfolios to provide the greatest patient benefit, and leveraging your experience across organizations both large and small.

Requirements

BA/BS with 20+ years, MS/MBA with 18+ years, or PhD with 15+ years of progressive pharmaceutical or life sciences experience in senior leadership roles
Proven track record in corporate strategy development, portfolio management, and strategic execution within or for large and small biopharmas
Experience leading integrated strategy across clinical-stage programs, including portfolio prioritization, development planning, and commercial positioning
Expertise in financial modeling, valuation methodologies (DCF, NPV, risk-adjusted valuations), and portfolio analytics
Experience delivering strategic initiatives through governance processes and managing ambiguity

Nice To Haves

Experience in infectious disease and/or oncology highly preferred
Biopharma strategy consulting experience, preferably with one of the premier management consulting firms preferred

Responsibilities

Lead the development and evolution of Vir Bio's long-term strategic plan in partnership with the CBO, executive leadership, and Board of Directors
Adapt corporate strategy in response to emerging clinical data, evolving market dynamics, and competitive landscape shifts
Working closely with the CEO, CBO, and CEO Chief of Staff, conceptualize and create board materials for quarterly board meetings and strategic offsites
Drive scenario planning and options analysis to inform critical business decisions and enable agile executive team decision-making
Contribute to investor communications and narratives supporting company growth
Design and manage strategic planning cycles, leadership meetings, and governance forums to enable clear priorities, decision-making, and execution tracking
Partner with the CBO and executive leadership to shape Vir Bio's long-term portfolio strategy, evaluating diversification pathways and strategic options under different capital, partnership, and market scenarios
Define portfolio strategy frameworks and valuation methodologies (NPV analysis, risk-adjusted valuations, scenario modeling) that inform corporate development priorities, investment decisions, and strategic prioritization
Develop and implement analytical frameworks and decision-making tools (including those leveraging AI/ML) that enhance organizational capabilities, driving data-driven strategic maturity and alignment across the organization
Conduct portfolio-level strategic analysis to identify gaps, optimize risk profile, and maximize financial returns, influencing business development target identification and deal thesis development in close partnership with senior leadership
Establish portfolio metrics, KPIs, and measurement frameworks to evaluate performance against strategic objectives, integrating competitive intelligence, emerging clinical data, and market insights into decision-making
Engage external advisors, consultants, and KOLs to inform portfolio strategy and validate strategic assumptions